Comparison of treatment regimes with adjustment for auxiliary variables

Journal of Applied Statistics

Volumn 38, Issue 12, 2011, Pages 2925-2938

  Tang, Xinyu ^a   Wahed, Abdus S ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

auxiliary variables; high risk neuroblastoma study; sequentially randomized design; time dependent covariates; treatment regime

Indexed keywords

EID: 84858193251     PISSN: 02664763     EISSN: 13600532     Source Type: Journal    
DOI: 10.1080/02664763.2011.573541     Document Type: Article

References (18)

1. Cox, D. R. 1972. Regression models and life-tables (with discussion). J. R. Statist. Soc. B, 34: 187-220.
2. Fleming, T. R. and Harrington, D. P. 1991. Counting Processes and Survival Analysis, Chichester: John Wiley and Sons.
3. Guo, X. and Tsiatis, A. A. 2005. A weighted risk estimator for survival distributions in two-stage randomization designs with censored survival data. Int. J. Biostat., 1: 1-15.
4. Leemis, L. M., Shih, L. H. and Reynertson, K. 1990. Variate generation for accelerated life and proportional hazard models with time dependent covariates. Stat. Probab. Lett., 10: 335-339.
5. Lokhnygina, Y. and Helterbrand, J. D. 2007. Cox regression methods for two-stage randomization designs. Biometrics, 63: 422-428.
6. Lunceford, J. K., Davidian, M. and Tsiatis, A. A. 2002. Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics, 58: 48-57.
7. Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., Gerbing, R. B. and Reynolds, C. P. 1999. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N. Engl. J. Med., 341: 1165-1173.
8. Matthay, K. K., Reynolds, C. P., Seeger, R. C., Shimada, H., Adkins, E. S., Haas-Kogan, D., Gerbing, R. B., London, W. B. and Villablanca, J. G. 2009. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study. J. Clin. Oncol., 27: 1007-1013.
9. Murphy, S. A. 2003. Optimal dynamic treatment regimes. J. R. Statist. Soc. Ser. B (Statist. Methodol.), 65: 331-355.
10. Murphy, S. A. and Bingham, D. 2009. Screening experiments for developing dynamic treatment regimes. J. Am. Statist. Assoc., 104: 391-409.
11. Murphy, S. A., Laanvan der, M. J. and Robins, J. M. 2001. Marginal mean models for dynamic regimes. J. Am. Statist. Assoc., 96: 1410-1423.
12. R Development Core Team. 2008. R: A Language and Environment for Statistical Computing, Vienna, Austria: R Foundation for Statistical Computing. Available at http://www.R-project.org
13. Robins, J. M., Rotnitzky, A. and Zhao, L. P. 1994. Estimation of regression coefficients when some regressors are not always observed. J. Am. Statist. Assoc., 89: 846-866.
14. ® Software: Changes and Enhancements, Cary, NC: Release 8.2, SAS Institute Inc.
15. Thall, P. F., Sung, H. G. and Estey, E. H. 2002. Selecting therapeutic strategies based on efficacy and death in multi-course clinical trials. J. Am. Statist. Assoc., 97: 29-39.
16. Therneau, T. M. and Grambsch, P. M. 2000. Modeling Survial Data: Extending the Cox Model, New York: Springer.
17. Wahed, A. S. and Tsiatis, A. A. 2004. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics, 60: 124-133.
18. Wahed, A. S. and Tsiatis, A. A. 2006. Semiparametric efficient estimation of survival distributions in two-stage randomization designs in clinical trials with censored data. Biometrika, 93: 163-177.